| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |